Home | | Pharmacology | Treatment with Insulin, Benefit of Glycemic Control in Diabetes Mellitus

Chapter: Basic & Clinical Pharmacology : Pancreatic Hormones & Antidiabetic Drugs

Treatment with Insulin, Benefit of Glycemic Control in Diabetes Mellitus

The current classification of diabetes mellitus identifies a group of patients who have virtually no insulin secretion and whose survival depends on administration of exogenous insulin.

Treatment with Insulin

The current classification of diabetes mellitus identifies a group of patients who have virtually no insulin secretion and whose survival depends on administration of exogenous insulin. This insulin-dependent group (type 1) represents 5–10% of the diabetic population in the USA. Most type 2 diabetics do not require exog-enous insulin for survival, but many need exogenous supplementa-tion of their endogenous secretion to achieve optimum health.

Benefit of Glycemic Control in Diabetes Mellitus

The consensus of the American Diabetes Association is that inten-sive glycemic control and targeting normal or near-normal glucose control associated with comprehensive self-management training should become standard therapy in diabetic patients (see Box: Benefits of Tight Glycemic Control in Diabetes). Exceptions include patients with advanced renal disease and the elderly, because the risks of hypoglycemia may outweigh the benefit of normal or near-normal glycemic control in these groups. In children under 7 years, the extreme susceptibility of the developing brain to incur damage from hypoglycemia contraindicates attempts at intensive glycemic control.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Basic & Clinical Pharmacology : Pancreatic Hormones & Antidiabetic Drugs : Treatment with Insulin, Benefit of Glycemic Control in Diabetes Mellitus |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.